Cargando…
Diabetes and Alzheimer’s Disease: Can Elevated Free Copper Predict the Risk of the Disease?
Background: Defective copper regulation, primarily referred to as chelatable redox active Cu(II), has been involved in the etiology of diabetes, and Alzheimer’s disease (AD). Objectives: However, no study has determined levels of labile copper non-bound to ceruloplasmin (non-Cp Cu, also known as ‘fr...
Autores principales: | Squitti, Rosanna, Mendez, Armando J., Simonelli, Ilaria, Ricordi, Camillo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302029/ https://www.ncbi.nlm.nih.gov/pubmed/27983558 http://dx.doi.org/10.3233/JAD-161033 |
Ejemplares similares
-
Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease
por: Squitti, Rosanna, et al.
Publicado: (2017) -
Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders 2013
por: Squitti, Rosanna, et al.
Publicado: (2013) -
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
por: Bagheri, Soghra, et al.
Publicado: (2018) -
Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Pal, Amit, et al.
Publicado: (2021) -
Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies
por: Squitti, Rosanna, et al.
Publicado: (2011)